Advertisement

U.S. markets open in 5 hours 47 minutes

S&P Futures
3,637.00
-24.00(-0.66%)
Dow Futures
29,038.00
-165.00(-0.57%)
Nasdaq Futures
11,223.75
-110.00(-0.97%)
Russell 2000 Futures
1,657.20
-11.20(-0.67%)
Crude Oil
77.10
-1.40(-1.78%)
Gold
1,625.20
-11.00(-0.67%)

Advertisement

Johnson & Johnson (JNJ)

NYSE - NYSE Delayed Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

164.94

-0.76

(-0.46%)

At close: 04:00PM EDT

165.60

+0.66

(+0.40%)

After hours:

07:51PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

Commodity Channel Index

View all chart patterns

Performance Outlook

Previous Close	165.70
Open	166.36
Bid	0.00 x 800
Ask	0.00 x 800
Day's Range	164.40 - 167.67
52 Week Range	155.72 - 186.69
Volume	8,626,039
Avg. Volume	6,850,988

Market Cap	433.657B
Beta (5Y Monthly)	0.61
PE Ratio (TTM)	24.01
EPS (TTM)	6.87
Earnings Date	Oct 18, 2022
Forward Dividend & Yield	4.52 (2.71%)
Ex-Dividend Date	Aug 22, 2022
1y Target Est	186.89

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

-14% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for JNJ

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Johnson & Johnson
Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
Rating
Fair Value
Economic Moat
9 days agoMorningstar